The Streetjournal Magazine is an online investigating media house that specializes on systematic, serious crimes, political corruption or corporate wrongdoing.
Read more about We are researching two candidates for Covid vaccines: Serum Institute CEO on Business Standard. In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity
Revealed: how the MENA region is battling the coronavirus pandemic arabianbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arabianbusiness.com Daily Mail and Mail on Sunday newspapers.
Uganda Allows Chinese Residents to Import Covid-19 Vaccine
A staff nurse at the Royal Cornwall Hospital prepares to administer Covid-19 vaccinations as the hospital began their vaccination programme on Dec. 9 in Truro, United Kingdom. Photo: Bloomberg
(Bloomberg) Uganda approved a request by Chinese residents to import 4,000 doses of a Covid-19 vaccine from their home country for their own use.
The inoculation will be provided to Chinese living in an industrial zone, about 58 kilometers (36 miles) northwest of the capital, Kampala, the Health Ministry said on its Twitter account.
The government “is not importing the Chinese Covid-19 vaccine for use by Ugandans,” the ministry said. The shot has yet to be approved by the World Health Organization, it said.
Text size
With Europe and the United States already beginning to vaccinate citizens against the Covid-19 disease, there are fears some countries may be left behind.
Here is a snapshot of what vaccines are being preferred around the Middle East and North Africa, and which treatments are being used to help those infected by the novel coronavirus.
Algeria
Treatment
Algeria opted early on to use hydroxychloroquine, along with antibiotics and cortisone treatments such as prednisolone or dexamethasone, and anti-coagulants, doctor Bekkat Berkani, a member of the national pandemic committee, told AFP.
There had been a campaign by labs to show that the anti-malarial drug hydroxychloroquine was inefficient or risked even being dangerous, he said. But he insisted about two billion people take it prophylactically for anti-malarial purposes around the world .